Acamar Partners Acquisition II registered today with the SEC to offer 35 million units at $10 each.
The new SPAC said it will target the consumer and retail sectors, including businesses operating in consumer branded products, food and beverage, luxury, fashion, lifestyle and leisure products and services, travel, and any technologies related to consumer and retail.
The SPAC is led by Chairman Juan Carlos Torres Carretero, who was a consultant at McKinsey & Co. before he became CEO and President of Seapharm, and founded Pharma Mar, a company that explored marine organic pharmaceutical agents.
Acamar Partners said it will apply for a Nasdaq listing under ACAMU. Read more.
